741
Views
62
CrossRef citations to date
0
Altmetric
Review

Cardiac crossroads: deciding between mechanical or bioprosthetic heart valve replacement

&
Pages 91-99 | Published online: 17 Feb 2011

References

  • JonesECDevereuxRBRomanMJPrevalence and correlates of mitral regurgitation in a population-based sample (the Strong Heart study)Am J Cardiol20018729830411165964
  • BachDSRadevaJIBirnbaumHGFournierAATuttleEGPrevalence, referral patterns, testing, and surgery in aortic valve disease: leaving women and elderly patients behindJ Heart Valve Dis20071636236917702360
  • PibarotPDumesnilJGProsthetic heart valves: selection of the optimal prosthesis and long-term managementCirculation20091191034104819237674
  • VongpatanasinWHillisLDLangeRAMedical progress prosthetic heart valvesN Engl J Med19963354074168676934
  • MastersRGHelouJPipeALKeonWJComparative clinical outcomes with St. Jude Medical, Medtronic Hall and CarboMedics mechanical heart valvesJ Heart Valve Dis20011040340911380109
  • VongpatanasinWHillisLDLangeRAProsthetic heart valvesN Engl J Med19963354074168676934
  • YacoubMRasmiNRHSundtTMFourteen-year experience with homovital homografts for aortic valve replacementJ Thorac Cardiovasc Surg199560110186
  • O’BrienMFStaffordEGGardnerMAAllograft aortic valve replacement: long-term follow-upAnn Thorac Surg199560S657646213
  • HammermeisterKESethiGKHendersonWGA comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis. Veterans Affairs Cooperative Study on Valvular Heart DiseaseN Engl J Med1993328128912968469251
  • PuvimanasingheJPASteyerbergEWTakkenbergJJMEijkemansEJvan HerwerdenLAPrognosis after aortic valve replacement with a bioprosthesis: predictions based on meta-analysis and microsimulationCirculation20011031535154111257081
  • HammermeisterKSethiGKHendersonWGOprianCRahimtoolaSHOutcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trialJ Am Coll Cardiol2000361152115811028464
  • OxenhamHBloomfieldPWheatleyDJTwenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprosthesesHeart20038971572112807838
  • RahimtoolaSHChoice of prosthetic heart valve for adult patientsJ Am Coll Cardiol20034189390412651032
  • Van GeldorpMJamiesonEKappeteinAPPatient outcome after aortic valve replacement with a mechanical or biological prosthesis: weighing lifetime anticoagulant-related event risk against reoperation riskJ Thorac Cardiovasc Surg200913788188619327512
  • RahimtoolaSHChoice of prosthetic heart valve in adults: an updateJ Am Coll Cardiol2010552413242620510209
  • The Stroke Prevention in Atrial Fibrillation InvestigatorsBleeding during antithrombotic therapy in patients with atrial fibrillationArch Intern Med19961564094168607726
  • ByethRQuinnLLandefeldCProspective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarinAm J Med199810591999727814
  • FihnSCallahanCMartinDMcDonellMHenikoffJWhiteRThe risk for and severity of bleeding complications in elderly patients treated with warfarinAnn Intern Med19961249709798624064
  • LandefeldCGoldmanLMajor bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapyAm J Med1989871441522787958
  • LandefeldCBeythRAnticoagulant-related bleeding. Clinical epidemiology, prediction, and preventionAm J Med1993953153288368229
  • LaunbjergJEgebladHHeafJNielsenNFuglehomALadefogedKBleeding complications to oral anticoagulant therapy: multivariate analysis of 1010 treatment years in 551outpatientsJ Intern Med19912293513552026988
  • PalaretiGLealiNCoccheriSBleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative studyLancet19963484234288709780
  • PalaretiGManottiCD’AngeloAThrombotic events during oral anticoagulant treatment: results of the inception cohort, prospective, collaborative ISCOAT studyThromb Haemost199778143814439423791
  • SteffensenFKristensenKEjlersenEDahlerupJSorensenHMajor haemorrhagic complications during oral anticoagulant therapy in a Danish population-based cohortJ Intern Med19972424975039437411
  • Van der MeerFRosendaalFVandenbrouckeJBrietEAssessment of a bleeding risk index in two cohorts of patients treated with oral anticoagulantsThromb Haesmost1996761216
  • BirkmeyerNJBirkmeyerJDTostesonANProsthetic valve type for patients undergoing aortic valve replacement: a decision analysisAnn Thorac Surg2000701946195211156100
  • De VincentiisCKunklABTrimarchiSAortic valve replacement in octogenarians: is biologic valve the unique solutionAnn Thorac Surg2008851296130118355513
  • HungLRahimtoolaSHProsthetic heart valves and pregnancyCirculation20031071240124612628941
  • BonowROCarabelloBAKanuCACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic SurgeonsCirculation200681114e84e23116880336
  • VahanianABaumgartnerHBaxJGuidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of CardiologyEur Heart J20072823026817259184
  • ChanVJamiesonWRGermannEPerformance of bioprostheses and mechanical prostheses assessed by composites of valve-related complications to 15 years after aortic valve replacementJ Thorac Cardiovasc Surg20061311267127316733156
  • KappeteinAPTakkenbergJPuvimanasingheJJamiesonWREijkemansMBogersADoes the type of biological valve affect patient outcomeInteract Cardiovasc Thorac Surg2006539840217670601
  • KulikAMastersRGBédardPPostoperative lipid-lowering therapy and bioprosthesis structural valve deterioration: justification for a randomised trialEur J Cardiothorac Surg20103713914419674916
  • CarpentierAHemodynamic factors affecting the fate of valvular bioprosthesisCirculation20101212083208420439782
  • KvidalPBergstromRHorteLGStableEObserved and relative survival after aortic valve replacementJ Am Coll Cardiol20003574775610716479
  • PuvimanasingheJPATakkenbergJJMEdwardsMComparison of outcomes after aortic valve replacement with a mechanical valve or a bioprosthesis using microsimulationHeart2004901172117815367517
  • GrunkemeierGJamiesonWMillerDStarrAActuarial versus actual risk of porcine structural valve deteriorationJ Thorac Cardiovasc Surg19941087097187934107
  • WhelanTLevineMWillanAEffect of a decision aid on knowledge and treatment decision making for breast cancer surgery: a randomized trialJAMA200429243544115280341
  • TakkenbergJJMPuvimanasingheJPAvan HerwerdenLADecision-making in aortic valve replacement: bileaflet mechanical valves versus stented bioprosthesesNeth Heart J200311510
  • CherDMiyamotoJLenertLIncorporating risk attitude into Markov-process decision models: importance for individual decision makingMed Decis Making1997173403509219195
  • BorrisLCRivaroxaban and dabigatran etexilate: two new oral anticoagulants for extended postoperative prevention of venous thromboembolism after elective total hip arthroplastyArch Orthop Trauma Surg201013058358919565250